• Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    Life can be better
    We are developing drug products isolated from plant extracts
    with history in traditional medicine.
  • Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    Improving health
    Improving health and wellbeing of the people
    is our ultimate goal at Mercury Pharmaceuticals.
  • Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    Mercury Pharmaceuticals
    ENTREPRENEURIAL MINDSET
    Hands-on approach to manage projects with proactivity and flexibility.

Welcome to Mercury Pharmaceuticals


We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.

More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.

Mercury Pharmaceuticals
Technology Assessment
Mercury Pharmaceuticals
Systems Research
Mercury Pharmaceuticals
Innovation Assessment
Mercury Pharmaceuticals
Clinical Trials

OUR Science

The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.

Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.

  • NeuroscienceAmong the global leaders in Neuroscience
  • OncologyTreatments for niche cancers.
  • Research & Development Building a sustainable R&D pipeline.
  • Clinical trialsTesting new treatments and ensure their efficacy and safety by conducting clinical trials.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

STAY INFORMED!

From wild rice to tarwi, researchers are exploring the health potential of Indigenous foods

28

Sep 2026

From wild rice to tarwi, researchers are exploring the health potential of Indigenous foods

A conference paper reviewed North American and Andean Indigenous foods, including Three Sisters crops, wild rice, native berries, tarwi, quinoa, and amaranth, and described their nutrients and bioactive compounds. Evidence for health effects remains limited for many of these foods, and the authors call for research developed with Indigenous communities that also supports traditional knowledge and food sovereignty.

READ MORE
From espresso to filter coffee, brewing may shape what reaches your gut

28

Sep 2026

From espresso to filter coffee, brewing may shape what reaches your gut

A focused narrative review traces how caffeine, chlorogenic acids, and coffee fibers move through the gut and interact with microbes. The authors identify plausible links between the microbiome and liver health, but human studies have not shown that microbiome changes cause coffee’s reported metabolic benefits.

READ MORE
An approved Ebola antibody may miss its mark against Bundibugyo virus

28

Sep 2026

An approved Ebola antibody may miss its mark against Bundibugyo virus

Researchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the virus’s glycoprotein. The models predicted disrupted binding for Ebanga, conserved targets for MBP134, and different binding behavior for the complete Inmazeb cocktail than for two of its antibodies alone; laboratory tests are needed to determine whether these findings translate into treatment benefit.

READ MORE

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.